SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Other Non Operating Income (2022 - 2025)

SeaStar Medical Holding's (ICU) quarterly Other Non Operating Income came in at -$246000.0 in Q2 2025, down 117.13% YoY from $1.4 million in Q2 2024, and down 564.15% on a QoQ basis from $53000.0 in Q1 2025.

SeaStar Medical Holding (ICU) Other Non Operating Income (2022 - 2025) Analysis & Trends

SeaStar Medical Holding (ICU) has 4 years of Other Non Operating Income data on file, last reported at -$246000.0 in Q2 2025.

  • Quarterly Other Non Operating Income fell 117.13% year-over-year to -$246000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $7.3 million (up 162.65% YoY) and the FY2025 annual result came in at -$3000.0, down 101.52% from the prior year.
  • Other Non Operating Income retreated to -$246000.0 in Q2 2025, from $53000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $7.5 million in Q4 2024 to a low of -$8.7 million in Q1 2024.
  • A 4-year average of -$457166.7 and a median of -$34500.0 in 2022 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2023 — Other Non Operating Income tumbled 3956.56% — and 2024, when it surged 1274.09%.
  • Tracing ICU's Other Non Operating Income over 4 years: stood at -$122000.0 in 2022, then soared by 549.18% to $548000.0 in 2023, then surged by 1274.09% to $7.5 million in 2024, then slumped by 103.27% to -$246000.0 in 2025.
  • The last three Other Non Operating Income figures came in at -$246000.0 (Q2 2025), $53000.0 (Q1 2025), and $7.5 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00

Historic Data

Download Data
DateValue
Jun 30, 2025 -246,000.00
Mar 31, 2025 53,000.00
Dec 31, 2024 7.53 Mn
Jun 30, 2024 1.44 Mn
Mar 31, 2024 -8.75 Mn
Dec 31, 2023 548,000.00
Sep 30, 2023 -4.95 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 -2.52 Mn
Sep 30, 2022 -122,000.00
Jun 30, 2022 410,000.00
Mar 31, 2022 -192,000.00